Article Information
History
- June 22, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sia Viborg Lindskrog1,2,28,
- Frederik F. Prip1,2,28,
- Philippe Lamy1,
- Ann Taber1,2,
- Clarice S. Groeneveld3,
- Karin Birkenkamp-Demtröder1,2,
- Jørgen Bjerggaard Jensen2,4,
- Trine Strandgaard1,2,
- Iver Nordentoft1,
- Emil Christensen1,2,
- Mateo Sokac1,2,
- Nicolai J. Birkbak1,2,
- Lasse Maretty1,2,
- Gregers G. Hermann5,
- Astrid C. Petersen6,
- Veronika Weyerer7,
- Marc-Oliver Grimm8,
- Marcus Horstmann8,9,
- Gottfrid Sjödahl10,
- Mattias Höglund11,
- Torben Steiniche12,
- Karin Mogensen5,
- Aurélien de Reyniès13,
- Roman Nawroth14,
- Brian Jordan15,
- Xiaoqi Lin15,
- Dejan Dragicevic16,
- Douglas G. Ward17,
- Anshita Goel17,
- Carolyn D. Hurst18,
- Jay D. Raman19,
- Joshua I. Warrick20,
- Ulrika Segersten21,
- Danijel Sikic22,
- Kim E.M. van Kessel23,
- Tobias Maurer14,24,
- Joshua J. Meeks15,
- David J. DeGraff20,
- Richard T. Bryan17,
- Margaret A. Knowles18,
- Tatjana Simic25,
- Arndt Hartmann7,
- Ellen C. Zwarthoff23,
- Per-Uno Malmström21,
- Núria Malats26,
- Francisco X. Real27 and
- Lars Dyrskjøt1,2,*
- 1Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Denmark
- 2Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark
- 3Cartes d’Identité des Tumeurs (CIT) Program, Ligue Nationale Contre le Cancer, Paris, 14 rue Corvisart 75013 Paris, France and Oncologie Moleculaire, UMR144, Institut Curie, 12 rue Lhomond, 75005 Paris, France
- 4Department of Urology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark
- 5Department of Urology, Herlev hospital, Copenhagen University, Borgmester Ib Juuls vej 23a, 2730 Herlev, Copenhagen, Denmark
- 6Department of Pathology, Aalborg University Hospital, Ladegaardsgade 3, 9000 Aalborg, Denmark
- 7Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Krankenhausstrasse 8-10, 91054 Erlangen, Germany
- 8Department of Urology, Jena University Hospital, Am Klinikum 1, 07747 Jena, Germany
- 9Department of Urology, Malteser Hospital St. Josephshospital, Krefeld Uerdingen, Kurfürstenstr. 69, 47829 Krefeld, Germany
- 10Division of Urological Research, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden
- 11Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden
- 12Department of Pathology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark
- 13Cartes d’Identité des Tumeurs (CIT) Program, Ligue Nationale Contre le Cancer, Paris, France
- 14Department of Urology, Technical University of Munich, Klinikum rechts der Isar, Ismaninger Str. 22, 81675 Munich, Germany
- 15Northwestern University School of Medicine, Chicago, Illinois, USA
- 16Clinic of Urology, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Resavska 51, 11000 Belgrade, Serbia
- 17Institute of Cancer and Genomic Sciences, College of Medicine and Dental Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom
- 18Leeds Institute of Medical Research at St James’s, University of Leeds, LS9 7TF, United Kingdom
- 19Department of Surgery, Division of Urology, Pennsylvania State University, 500 University Drive, Hershey Pennsylvania, 17033, USA
- 20Department of Pathology and Laboratory Medicine, Department of Surgery Division of Urology, Department of Biochemistry and Molecular Biology, Pennsylvania State University, 500 University Drive, Hershey Pennsylvania, 17033, USA
- 21Department of Surgical Sciences, Uppsala University, Uppsala 751 85, Sweden
- 22Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Krankenhausstrasse 12, 91054 Erlangen, Germany
- 23Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Na-1710, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands
- 24Department of Urology and Martini-Clinic, University Medical Center Hamburg-Eppendorf, Martini-Str. 52, 20246 Hamburg, German
- 25Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, Pasterova 2, 11000 Belgrade, Serbia
- 26Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029-Madrid, and CIBERONC, Spain
- 27Epithelial Carcinogenesis Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029-Madrid; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, 08003-Barcelona; and CIBERONC, Spain
- ↵*corresponding author; email: lars{at}clin.au.dk
↵28 Equal contribution
Posted June 22, 2020.
An integrated multi-omics analysis identifies clinically relevant molecular subtypes of non-muscle-invasive bladder cancer
